Nexo Therapeutics is a biopharmaceutical company focused on drug discovery for elusive drug targets in various disease areas. The company aims to address challenges in drug development by finding quality ligands for targets and understanding the pharmacology required to effectively modulate these targets.

Nexo Therapeutics

Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.

Nexo Therapeutics has received reports of employment scams that purport to extend job offers or seek financial commitments from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) claiming to be or represent Nexo recruiter(s). Be advised that Nexo is not recruiting any for data entry roles and does not extend unsolicited employment offers. Furthermore, Nexo does not charge prospective employees any fees or a security deposit nor do we ask for any bank account information during the recruitment process . If a person claims to provide recruitment services for Nexo for a fee to the applicant or offers an unsolicited job offer, please be advised that the person is not affiliated in any way with Nexo.

If you are interested in an employment opportunity with Nexo Therapeutics, please visit our official page on LinkedIn for any listings. All active searches will be listed and any job postings that do not link to this page are not legitimate and might be fraudulent.

You may report any such behavior via info@nexotx.com. If you have been defrauded or suspect identity theft as a result of an employment scam, please contact your local law enforcement agency for guidance.

Metric
Company Name	Nexo Therapeutics
Symbol
MSH ID	COM:NEXOTX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology and Pharmaceuticals
Country	US
Stage
Employee Count
Website	nexotx.com
LinkedIn	nexo-therapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NEXO

COM:NEXOTX

Nexo Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue